Treatment of Rhinosinusitis
The first-line treatment for rhinosinusitis should be intranasal corticosteroids and nasal saline irrigation, with antibiotics reserved only for specific cases of bacterial infection that meet strict diagnostic criteria. 1
Classification and Diagnosis
Rhinosinusitis is classified based on duration:
- Acute rhinosinusitis (ARS): symptoms lasting less than 4 weeks
- Viral rhinosinusitis (VRS): most common, self-limiting
- Post-viral rhinosinusitis: symptoms worsening after 5 days or persisting beyond 10 days
- Acute bacterial rhinosinusitis (ABRS): small percentage (0.5-2%) of cases
- Chronic rhinosinusitis (CRS): symptoms lasting more than 12 weeks
- With nasal polyps (CRSwNP)
- Without nasal polyps (CRSsNP)
Diagnostic Criteria for Bacterial Rhinosinusitis
Antibiotics should be reserved for patients with:
- Symptoms persisting for more than 10 days without improvement
- Severe symptoms (fever >39°C, purulent nasal discharge, facial pain) for at least 3 consecutive days
- "Double sickening" pattern (worsening symptoms after initial improvement) 1
Treatment Algorithm
1. Acute Viral Rhinosinusitis (Common Cold)
- First-line: Symptomatic treatment only 1
- Analgesics/antipyretics for pain and fever
- Nasal saline irrigation
- Short-term decongestants (≤3-5 days to avoid rebound congestion)
- Intranasal corticosteroids may provide modest benefit
2. Post-viral Rhinosinusitis
- First-line:
- Not recommended: Systemic corticosteroids (benefit does not outweigh potential harm) 1
3. Acute Bacterial Rhinosinusitis
- First-line options (choose one):
- Adjunctive therapy:
- Intranasal corticosteroids
- Nasal saline irrigation
4. Chronic Rhinosinusitis Without Nasal Polyps
- First-line:
- Second-line (if no improvement after 3 months):
- Third-line (if still no improvement):
- Referral to otolaryngologist for evaluation for sinus surgery 1
5. Chronic Rhinosinusitis With Nasal Polyps
- First-line:
- Intranasal corticosteroid drops/sprays 1
- Second-line (if no improvement after 3 months):
- Short course of oral corticosteroids (1 month) 1
- Third-line (if still no improvement):
- Referral to otolaryngologist for evaluation for sinus surgery 1
Specific Medications
Intranasal Corticosteroids
- Mechanism: Reduce inflammation in nasal passages
- Examples: Fluticasone propionate
- Benefits: May provide relief starting from first day of use, with full effectiveness after several days 2
- Side effects: Minor - occasional nasal irritation, sneezing, or minor nosebleeds 2
Nasal Saline Irrigation
- Mechanism: Mechanical cleansing, improved mucociliary clearance
- Benefits: Low risk, improves symptoms, may reduce need for other medications 1
- Evidence: High aggregate quality of evidence supports effectiveness 3
Decongestants
- Mechanism: Reduce nasal congestion through vasoconstriction
- Caution: Topical decongestants (e.g., oxymetazoline) should not be used for more than 3-5 days due to risk of rebound congestion (rhinitis medicamentosa) 1, 4
Antibiotics
- Indications: Only for confirmed or strongly suspected bacterial infection
- First choice: Amoxicillin with or without clavulanate 1
- Duration: 5-10 days for acute bacterial rhinosinusitis 1
- Caution: Overuse contributes to antibiotic resistance; 60% of presumed bacterial cases resolve spontaneously 1
Important Considerations
When to Refer to a Specialist
- Failure to respond to appropriate medical therapy
- Recurrent episodes of acute rhinosinusitis
- Complications (orbital, intracranial)
- Suspected fungal sinusitis or immunodeficiency
- Presence of nasal polyps or anatomical abnormalities 1
Common Pitfalls to Avoid
- Overuse of antibiotics: Most cases of rhinosinusitis are viral and self-limiting 1
- Prolonged use of topical decongestants: Can lead to rebound congestion 1
- Inadequate duration of intranasal corticosteroid therapy: Full benefits may take several days to develop 2
- Assuming colored nasal discharge indicates bacterial infection: Discoloration relates to neutrophils, not necessarily bacteria 1
- Failure to address underlying conditions: Allergies, immunodeficiency, or anatomical issues may require specific management 1
By following this evidence-based approach to rhinosinusitis management, clinicians can improve patient outcomes while reducing unnecessary antibiotic use and healthcare costs.